Details for 2019214405
Up to date per 02.04.2026
Actions
Details for 2019214405
Granted/Registered
European Patent
22.07.2020 A
10.11.2021 B1
06.06.2011
US
201161493536 P
C07D 213/81 20060101AFI20210416BHEP
Owner
Akebia Therapeutics Inc.245 First Street, Suite 1100 Cambridge, MA 02142US
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
LANTHIER, Christopher, M. Burlington, Ontario L7M 3YACA
GORIN, Boris Oakville, Ontario L6H 6A8CA
OUDENES, Jan Aurora, Ontario L4G 6W6CA
DIXON, Craig, Edward Brooklin, Ontario L1M 0G7CA
LU, Alan, Qingbo Mississauga, Ontario L5M 7W4CA
COPP, James, Densmore Bargersville, IN 46106US
JANUSZ, John, Michael West Chester, OH 45069US
Information about Fees